This argument is supported by the observation that the effects of GCN2 depletion on clonal survival and drug resistance is less severe in the non-cancerous MEFs compared with the drug sensitive and resistant MCF-7 breast cancer cells. This evidence concerns the gene EIF2AK4 and breast carcinoma.